Report Analyzes Hospital Antibiotic Prescribing Practices for the Management of Osteomyelitis
December 12, 2011—Exton, Penn.—Arlington Medical Resources (AMR), a provider of premier market intelligence for the pharmaceutical and diagnostic imaging industries, will release analysis of treatment practices and antibiotic prescribing patterns for the management of osteomyelitis.
Hospital Insight Series: Osteomyelitis will provide insight and analysis of the osteomyelitis market in the United States, including segmentation of the osteomyelitis patient population by treatment setting (outpatient versus hospital), disease severity, type of osteomyelitis, outcomes, co-morbid conditions and risk of infection with key pathogens. Moreover this study will evaluate key prescribers in the hospital setting and key specialists involved in the management of osteomyelitis post-hospital discharge.
The report will also focus on key therapies used in the treatment of osteomyelitis in the hospital and outpatient settings, addressing challenges in treating patients and likely treatment trends over the next five years. Included in the analysis is primary research with infectious disease specialists to understand physicians’ preference for and experience with osteomyelitis therapies.
“Through clinical audit data and prirmary research with infectious disease specialists, we are able to understand physicians’ treatment patterns when treating osteomyelitis,” said AMR Analyst Brenda Perez-Cheeks, Ph.D. “We can also identify factors that influence current and future prescribing patterns as well as challenges in treating osteomyelitis in both inpatient and outpatient settings.”
About Arlington Medical Resources, LLC
AMR (
www.AMR-data.com) serves the market intelligence needs of the pharmaceutical and diagnostic imaging industries. Research includes clinical inpatient databases that directly link anti-infective drug with indication/procedure, formulary and stocking status tracking studies, drug purchasing audits and diagnostic imaging procedure volume/contrast media usage audits. AMR is a Decision Resources Group company.
About Decision Resources Group
Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Group at
www.DecisionResourcesGroup.com.
###
All company, brand or product names contained in this document may be trademarks or
registered trademarks of their respective holders.